Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hirokazu Onodera"'
Autor:
Norio Hanafusa, Ayako Isoai, Tomoaki Ishihara, Tetsuya Inoue, Ken Ishitani, Taiju Utsugisawa, Toshihiko Yamaka, Tetsuya Ito, Hiroshi Sugiyama, Atsushi Arakawa, Yosuke Yamada, Yasuo Itano, Hirokazu Onodera, Ryosuke Kobayashi, Naoko Torii, Toyoko Numata, Taihei Kashiwabara, Yoshihiro Matsuno, Michio Kato
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177303 (2017)
We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were performed. The most common primary disease wa
Externí odkaz:
https://doaj.org/article/7affb2ecce05439796224d035af5cf8b
Autor:
Hirokazu Onodera, Ken Ishitani, Hiroshi Sugiyama, Taiju Utsugisawa, Yoshihiro Matsuno, Ayako Isoai, Ryosuke Kobayashi, Noriko Soneda, Yosuke Yamada, Michio Kato, Naoko Torii, Tetsuya Ito, Atsushi Arakawa, Norio Hanafusa
Publikováno v:
International Journal of Clinical Oncology. 26:1130-1138
Cell-free and concentrated ascites reinfusion therapy (CART) has been suggested to be able to treat malignant ascites more safely and effectively with chemotherapy because of its ability to retain serum protein and albumin. Although the characteristi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db0a11136babe66c92ceb24f9bc018c
https://doi.org/10.1007/s10147-021-01883-2
https://doi.org/10.1007/s10147-021-01883-2
Autor:
Hirokazu Onodera, Ayako Isoai, Yoshihiro Matsuno, Ryosuke Kobayashi, Hitoshi Kanno, Taiju Utsugisawa, Michio Kato
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 64:631-640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6905b64deeb05f825a952866c3c7600e
https://doi.org/10.3925/jjtc.64.631
https://doi.org/10.3925/jjtc.64.631
Autor:
Hidenori Matsuo, Izumi Ohtsuru, Noritoshi Shibuya, Makoto Yoshida, Megumi Yoshinaga-Matsumoto, Hirokazu Onodera, Hirofumi Goto, Shunya Nakane, Katsuhiro Ichinose
Publikováno v:
Multiple Sclerosis Journal. 9:579-584
Experimental autoimmune encephalomyelitis (EAE) is a major animal model of human multiple sclerosis (MS). CD4+ T cells are thought to play a pivotal role in the patho genesis of EAE and MS. In order to investigate the depletio n of CD4+ T cells from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6a0243be9258ba7f0b128dda158cef
https://doi.org/10.1191/1352458503ms968oa
https://doi.org/10.1191/1352458503ms968oa
Publikováno v:
Therapeutic Apheresis and Dialysis. 7:329-333
To control antigen (Ag)-specific immune cells is important in the treatment of autoimmune diseases. In particular, controlling the immune response of autoimmune T cells is effective in the treatment of these diseases. The development of a device that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599d12bb5e260c7becf8c18833476555
https://doi.org/10.1046/j.1526-0968.2003.00050.x
https://doi.org/10.1046/j.1526-0968.2003.00050.x
Autor:
Hirokazu Onodera, Yumi Abe, Makoto Yoshida, Naokuni Yamawaki, Yasuhiko Yamashita, Hidenori Matsuo, Katsuhiro Ichinose, Izumi Otsuru, Noritoshi Shibuya
Publikováno v:
Therapeutic Apheresis. 4:161-166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d734b089b7eb24d10d56b7a4ebebe423
https://doi.org/10.1046/j.1526-0968.2000.004002161.x
https://doi.org/10.1046/j.1526-0968.2000.004002161.x
Autor:
Satoshi Fujishit, Hirokazu Onodera, Naokuni Yamawaki, Noritoshi Shibuya, Junsuke Suematsu, Izumi Ohtsuru, Hidenori Matsuo, Katsuhiro Ichinose, Makoto Yoshida
Publikováno v:
Therapeutic Apheresis. 1:165-168
Experimental allergic encephalomyelitis (EAE) is a major animal model of human multiple sclerosis (MS). The pathogenesis of both MS and EAE directly involves CD4+ helper T cells. To remove CD4+ T cells selectively from the circulation, we designed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2aa905160c8c8d818c7ace4c86b396
https://doi.org/10.1111/j.1744-9987.1997.tb00034.x
https://doi.org/10.1111/j.1744-9987.1997.tb00034.x
Autor:
Noritoshi Shibuya, Hidenori Matsuo, Hirokazu Onodera, Takayasu Fukudome, Chiaki Kambara, Hirofumi Goto, Takamitsu Mizota, Makoto Yoshida
Publikováno v:
Therapeutic Apheresis and Dialysis. 8:194-196
The pathogenesis of most autoimmune diseases directly involves CD4(+) helper T cells. To remove CD4(+) T cells selectively from the circulation, we designed a new column in which an anti-CD4 monoclonal antibody was immobilized on the activated substa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14e9d12181ef1d678f7b0effa196995
https://doi.org/10.1111/j.1526-0968.2004.00146.x
https://doi.org/10.1111/j.1526-0968.2004.00146.x
Publikováno v:
World Congress on Medical Physics and Biomedical Engineering 2006 ISBN: 9783540368397
Leukocytapheresis has an achieved well therapeutic efficacy in inflammatory bowel disease such as ulcerative colitis and rheumatoid arthritis in Japan. It has been applied in clinical therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e0e1be9355314530f7f5a1fb93ffba
https://doi.org/10.1007/978-3-540-36841-0_652
https://doi.org/10.1007/978-3-540-36841-0_652
Autor:
Naokuni Yamawaki, Noritoshi Shibuya, Katsuhiro Ichinose, Makoto Yoshida, Izumi Otsuru, Hidenori Matsuo, Hirokazu Onodera, Yasuhiko Yamashita, Yumi Abe
Publikováno v:
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis. 2(1)
Guest Editor's Introduction: As the leukocyte removal has been recognized as an effective means of therapy, efforts were focused on the device development for more specific removal of cellular components, which are related to the cause of the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6171c2e53dde948733dcd3d11f1a6f5e
https://pubmed.ncbi.nlm.nih.gov/10227787
https://pubmed.ncbi.nlm.nih.gov/10227787